The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients

BACKGROUND: CD133 (prominin-1) is widely believed to be a cancer stem cell marker in various solid tumor types, and CD133 has been correlated with tumor-initiating capacity. Recently, the nuclear location of CD133 expression in tumors has been discussed, but hepatocellular carcinoma (HCC) has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yao-Li, Lin, Ping-Yi, Ming, Ying-Zi, Huang, Wei-Chieh, Chen, Rong-Fu, Chen, Po-Ming, Chu, Pei-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501948/
https://www.ncbi.nlm.nih.gov/pubmed/28687090
http://dx.doi.org/10.1186/s12885-017-3460-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501948/
https://www.ncbi.nlm.nih.gov/pubmed/28687090
http://dx.doi.org/10.1186/s12885-017-3460-9

Ejemplares similares